Chondroprotective potential of fruit extracts of Phyllanthus emblica in osteoarthritis

Evidence-based Complementary and Alternative Medicine

Volumn 5, Issue 3, 2008, Pages 329-335

  Sumantran, Venil N ^a   Kulkarni, Asavari ^a   Chandwaskar, Rucha ^a   Harsulkar, Abhay ^a   Patwardhan, Bhushan ^b   Chopra, Arvind ^c   Wagh, Ulhas V ^a  

^a Bharati Vidyapeeth Deemed University   (India)

^b UNIVERSITY OF PUNE   (India)

^c Center for Rheumatic Diseases   (India)

Author keywords

Collagenase; Glycosaminoglycans; Hyaluronidase; Phyllanthus emblica

Indexed keywords

CHONDROPROTECTIVE AGENT; COLLAGENASE; COLLAGENASE TYPE 2; EMBLICA OFFICINALIS EXTRACT; GLUCOSAMINE SULFATE; GLYCOSAMINOGLYCAN; HYALURONIDASE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; ARTICULAR CARTILAGE; AYURVEDA; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CHONDROPATHY; CHONDROPROTECTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DETERMINATION; EMBLICA OFFICINALIS; ENZYME ACTIVITY; EXPLANT; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MEDICINAL PLANT; OSTEOARTHRITIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 51849097364     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nem030     Document Type: Article

References (24)

1. Richy F, Bruyere O, Ethgen O, Cucherat M, Henerotin Y, Reginister JY. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med 2003;163:1514-22.
2. Cibere J, Kopec JA, Thorne A, Singer J, Canvin J, Robinson DB, et al. Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum 2004;51:738-45.
3. da Camara CC, Dowless GV. Glucosamine sulfate for osteoarthritis. Ann Pharmacother 1998;32:580-7.
4. NIH Glucosamine and Chondroitin Arthritis Intervention (GAIT) trial. NCCAM Publication No. D310. Updated: February 2006.
5. Svoboda RE. Ayurvedic Life Health and Longevity. Penguin Books India Ltd., 1992, 161.
6. Milner JM, Elliot SF, Cawston TE. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways. Arthritis Rheumatism 2001;44:2084-96.
7. Patent filed by Takara Shuzo Co. Ltd., Pub No. JP 11-071290, 1999.
8. Sugimoto K, Iizawa T, Harada H, Yamada K, Katsumata M, Takahashi M. Cartilage degradation independent of MMP/aggrecanases. Osteoarthr Cartilage 2004;12:1006-14.
9. Blot L, Marcelis A, Devogelaer J, Manicourt DH. Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritis human cartilage. Br J Pharmacol 2000;131:1413-21.
10. Squires GR, Okuneff S, Lonescu M, Poole AR. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Arthritis Rheum 2003;48:1261-70.
11. Uitterlinden EJ, Jahr H, Koevoet JL, Jenniskens YM, Bierma-Zeinstra SM, Degroot J, et al. Glucosamine decreases expression of anabolic and catabolic genes in human osteoarthritic cartilage explants. Osteoarthr Cartilage 2006;14:250-7. Epub November 18, 2005.
12. Patwari P, Kurz B, Sandy JD, Grodinsky AJ. Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage. Arch Biochem Biophys 2000;374:79-85.
13. Harsulkar AM, Giri AP, Gupta VS, Sainani MN, Deshpande VV, Patankar AG, et al. Characterization of Helicoverpa armigera gut proteinases and their interaction with proteinase inhibitors using gel X-ray film contact print technique. Electrophoresis 1998;19:1397-402.
14. Tung JS, Mark GE, Hollis GF. A microplate assay for hyaluronidase and hyaluronidase inhibitors. Anal Biochem 1994;223:149-52.
15. Outerbridge RE. The etiology of chondromalacia patellae. J Bone Joint Surg 1961;43-B:752-7.
16. Hoemann CD, Sun J, Chrzanowski V, Bhushman MD. A Multivalent assay detect glycosaminoglycan, protein, collagen, RNA, and DNA content in milligram samples of cartilage or hydrogel-based repair cartilage. Anal Biochem 2002;300:1-10.
17. Springman EB, Nagase H, Birkedal-Hansen H, Van Wart HE. Zinc content and function in human fibroblast collagenase. Biochemistry 1995;34:15713-20.
18. Dodge GR, Jimenez SA. Glucosamine sulfate modulates the levels of the aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes. Osteoarthr Cartilage 2003;11:424-32.
19. Neetu D, Yogesh B, Anju B, Dipti P, Pauline T, Sharma SK, et al. Cyto-protective and immunomodulating properties of Amla (Emblica officinalis) on lymphocytes: an in vitro study. J Ethnopharmacol 2002;81:5-10.
20. Rajak S, Banerjee SK, Sood S, Dinda Ak, Gupta YK, Gupta SK, et al. Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic-reperfusion injury in rats. Phytother Res 2004;18:54-60.
21. Marquina MA, Coroa GM, Araujo L, Buitrago D, Sosa M. Hyaluronidase inhibitory activity from the polyphenols in the fruit of blackberry (Rubus fruticosus B.). Fitoterapia 2002;73:727-9.
22. Demeule M, Brossard M, Page M, Gingras D, Beliveau R. Matrix metalloproteinase inhibition by green tea catechins. Biochem Biophys Acta 2000;1478:51-60.
23. Pelletier JP, Martel-Pelletier J. Effects of nimesulide and naproxen on the degradation and metalloprotease synthesis of human osteoarthritic cartilage. Drugs 1993;46 (Suppl 1):34-9.
24. Smith GN Jr, Yu LP Jr, Brandt KD, Capello WN. Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage. J Rheumatol 1998;25:532-5.